Lifecare ASA announces that the company's Chief Financial Officer (CFO),
Renete Kaarvik, has accepted a new position outside Lifecare. She will remain
in her role during a transition period, including throughout the ongoing
rights issue, to ensure continuity in the company's financial processes.
Kaarvik will subsequently step down as CFO.
The new position does not give rise to any conflicts of interest. Arrangements
are being made to ensure continuity of the CFO function.
About us
Lifecare ASA is a medical sensor company developing technology for sensing and
monitoring of various body analytes. Lifecare's focus is to bring the next
generation of Continuous Glucose Monitoring systems to market. Lifecare
enables osmotic pressure as sensing principle. Lifecare's sensor technology is
suitable for identifying and monitoring the occurrence of a wide range of
analytes and molecules in the human body and in pets.
Contacts
For further information, please contact:
Joacim Holter, CEO, joacim.holter@lifecare.no, +47 40 05 90 40
Renete Kaarvik, CFO, renete.kaarvik@lifecare.no, +47 94 83 82 42
This information has been submitted pursuant to the Securities Trading Act ยง
5-12 and MAR Article 17. The information was submitted for publication,
through the agency of the contact persons set out above, at 2026-01-05 22:38
CET.